Luo Zhenkai, Jiao Binbin, Zhao Hang, Huang Tao, Liu Yuhao, Chen Haijie, Guan Yunfan, Zhang Guan, Jiang Zhaoqiang
Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, No. 17 Nanli, Panjiayuan, Chaoyang District, Beijing, 100730, China.
Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Nanli, Panjiayuan, Chaoyang District, Beijing, 100021, China.
Clin Transl Oncol. 2024 Jan;26(1):136-146. doi: 10.1007/s12094-023-03226-1. Epub 2023 Jun 5.
To compare the predictive performance of the current clinical prediction models for predicting intravesical recurrence (IVR) after radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).
We retrospectively analysed upper tract urothelial carcinoma patients who underwent radical nephroureterectomy in our centre from January 2009 to December 2019. We used the propensity score matching (PSM) method to adjust the confounders between the IVR and non-IVR groups. Additionally, Xylinas' reduce model and full model, Zhang's model, and Ishioka's risk stratification model were used to retrospectively calculate predictions for each patient. Receiver operating characteristic (ROC) curves were generated, and the areas under the curves (AUCs) were compared to identify the method with the highest predictive value.
We included 217 patients with a median follow-up of 41 months, of which 57 had IVR. After PSM analysis, 52 pairs of well-matched patients were included in the comparative study. No significant difference was found in clinical indicators besides hydronephrosis. The model comparison showed that the AUCs of the reduced Xylinas' model for 12 months, 24 months, and 36 months were 0.69, 0.73, and 0.74, respectively, and those of the full Xylinas' model were 0.72, 0.75, and 0.74, respectively. The AUC of Zhang's model for 12 months, 24 months, and 36 months was 0.63, 0.71, and 0.71, respectively, the performance of Ishioka's model is that the AUC of 12 months, 24 months and 36 months was 0.66, 0.71, and 0.74, respectively.
The external verification results of the four models show that more comprehensive data and a larger sample size of patients are needed to strengthen the models' derivation and updating procedure, to better apply them to different populations.
比较目前临床预测模型对预测上尿路尿路上皮癌(UTUC)患者根治性肾输尿管切除术(RNU)后膀胱内复发(IVR)的预测性能。
我们回顾性分析了2009年1月至2019年12月在本中心接受根治性肾输尿管切除术的上尿路尿路上皮癌患者。我们使用倾向评分匹配(PSM)方法来调整IVR组和非IVR组之间的混杂因素。此外,使用Xylinas的简化模型和完整模型、Zhang的模型以及Ishioka的风险分层模型对每位患者进行回顾性预测计算。生成受试者操作特征(ROC)曲线,并比较曲线下面积(AUC)以确定预测价值最高的方法。
我们纳入了217例患者,中位随访时间为41个月,其中57例发生IVR。经过PSM分析,52对匹配良好的患者被纳入比较研究。除肾盂积水外,临床指标未发现显著差异。模型比较显示,Xylinas简化模型在12个月、24个月和36个月时的AUC分别为0.69、0.73和0.74,Xylinas完整模型的AUC分别为0.72、0.75和0.74。Zhang模型在12个月、24个月和36个月时的AUC分别为0.63、0.71和0.71,Ishioka模型在12个月、24个月和36个月时的AUC分别为0.66、0.71和0.74。
四个模型的外部验证结果表明,需要更全面的数据和更大样本量的患者来加强模型的推导和更新程序,以便更好地将它们应用于不同人群。